Mekophar estimates to earn 40b dong of Jan-May profit

In the first five months of this year, Mekophar Chemical Pharmaceutical Joint Stock Co (coded MKP) reported to reach total revenue of 300 billion dong, pre-tax profit of 40 billion dong, and export turnover of over $2 million.

In comparison with the 2010 business plan of targeted revenue of 720 billion dong and pre-tax profit of 720 billion dong, the company has already fulfilled 41.6 percent of revenue plan and 52.3 percent of profit plan.

The company made debut session on Hochiminh Stock Exchange (STC) on June 2, 2010. Mekophar mainly operates in producing, trading, importing and exporting pharmaceutical products, raw materials, chemical substances and medical tools with over 300 types of products.

In 2009, MKP was listed in top-ten list of largest pharmaceutical producers, with highest sales revenue in the market.

Tags: Mekophar, vietnam stock, Vietnam stock market

Posted by VBN on Jun 7 2010. Filed under Health & Drugs, Stock. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry